BMEMat最新文献

In the “CONFLICT OF INTEREST STATEMENT” section, the text “The authors declare no competing financial interests.” is incomplete.

This should be corrected to “Changyou Gao is an editorial board member of the BMEMat journal and was not involved in the editorial review or the decision to publish this article. All authors declare no competing financial interest.”

We apologize for this error.

In the “CONFLICT OF INTEREST STATEMENT” section, the text “The authors declare no conflict of interest.” is incomplete.

This should be corrected to “Yanglong Hou is an editorial board member of BMEMat journal and was not involved in the editorial review or the decision to publish this article. All authors declare no competing interests.”

We apologize for the error.

In the “CONFLICT OF INTEREST STATEMENT” section, the text “The authors declare no conflict of interest.” is incomplete.

This should be corrected to “Wei Huang and Xiaocheng Dong are the editorial board member of BMEMat journal and were not involved in the editorial review or the decision to publish this article. All authors declare no competing interests.”

We apologize for this error.

In the “CONFLICT OF INTEREST STATEMENT” section, the text “The authors declare no competing financial interests.” is incomplete.

This should be corrected to “Qiangbin Wang is an editorial board member of the BMEMat journal and was not involved in the editorial review or the decision to publish this article. All authors declare no competing financial interests.”

We apologize for the error.

In the “CONFLICT OF INTEREST STATEMENT” section, the text “The authors declare no conflict of interest.” is incomplete.

This should be corrected to “Guangjun Nie is an editorial board member of BMEMat journal and was not involved in the editorial review or the decision to publish this article. All authors declare no competing interests.”

We apologize for the error.

In the “CONFLICT OF INTEREST STATEMENT” section, the text “The authors declare no competing financial interests.” is incomplete.

This should be corrected to “Dong Ming is an editorial board member of the BMEMat journal and was not involved in the editorial review or the decision to publish this article. All authors declare no competing financial interests.”

We apologize for this error.

In the “CONFLICT OF INTEREST STATEMENT” section, the text “The authors declare no conflicts of interest.” is incomplete.

This should be corrected to “Xian Jun Loh is an editorial board member of the BMEMat journal and was not involved in the editorial review or the decision to publish this article. All authors declare no competing interests.”

We apologize for this error.

In the quest for optimizing biodegradable implants, the exploration of piezoelectric materials stands at the forefront of biomedical engineering research. Traditional piezoelectric materials often suffer from limitations in biocompatibility and biodegradability, significantly impeding their in vivo study and further biomedical application. By leveraging molecular engineering and structural design, a recent innovative approach transcends the conventional piezoelectric limits of the molecules designed for biodegradable implants. The biodegradable molecular piezoelectric implants may open new avenues for their applications in bioenergy harvesting/sensing, implanted electronics, transient medical devices and tissue regeneration.

Carbon dots (CDs), emerging as a promising class of nanomaterials, have garnered significant interest in the field of biomedicine due to their unique physicochemical properties. This review provides a comprehensive overview of the recent advancements in the biomedical applications of CDs, emphasizing their potential for revolutionizing diagnostics, therapy, and bio-imaging. We discuss the synthesis and functionalization of CDs, which are pivotal in tailoring their properties for specific biomedical applications. The applications of CDs in bioimaging include fluorescence imaging, magnetic resonance imaging, photoacoustic imaging, etc. Additionally, this review delves into the benefits of CDs in the treatment of diseases including cancer, inflammation and Alzheimer's, etc. Finally, we look forward to the future of CDs in the field of biomedicine, emphasizing the necessity of interdisciplinary collaboration to overcome current obstacles and facilitate the clinical translation of CDs-based technologies. This review aims to provide a summary and perspectives on the latest developments of CDs in biomedicine, hoping to inspire further research in this rapidly advancing field.

The emergence of multidrug-resistant bacteria poses a significant challenge in the treatment of osteomyelitis, rendering traditional antibiotic treatment strategies inadequate in terms of achieving a complete cure. In recent years, triggerable biomaterial-based, antibiotic-free osteomyelitis treatment strategies have rapidly evolved, demonstrating excellent bactericidal effects. Triggerable biomaterials-based osteomyelitis theranostics encompass physical signal response strategies and host immune modulation approaches. These strategies can be effective against drug-resistant bacteria, circumventing the gradual acquisition of resistance that often accompanies traditional antibiotic treatment. Additionally, the inherent physical properties of the triggerable biomaterials facilitate the precise imaging of osteomyelitis. There is no doubt that triggerable biomaterial-mediated, antibiotic-free therapies are emerging as a trend, which is critically important in combating multidrug-resistant bacteria-induced osteomyelitis. In this review, we summarize the latest advances in osteomyelitis treatment strategies from both pathogen-directed and host-directed perspectives. The design regimens and specific action mechanisms of triggerable biomaterial-based nanoplatforms are also clarified. Finally, we outline the challenges faced by various antibiotic-free therapies and provide an outlook on the prospects for synergistic interactions.